New scan and blood test aim to spot brain tumor return sooner
NCT ID NCT07447531
Summary
This study is testing whether a special type of MRI scan and a blood test can help doctors better predict how an aggressive brain tumor (glioblastoma) might change or return after treatment. Researchers will enroll 15 adults with a new diagnosis to see if these tools can spot signs of tumor progression earlier than current methods. The goal is to gather knowledge that could improve future monitoring, not to provide a new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Iowa Health Care
RECRUITINGIowa City, Iowa, 52245, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.